You are here
RADIX PHARMACEUTICALS, INC.
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of Small Molecules as Antiprotozoal Agents
Amount: $1,240,336.00DESCRIPTION (provided by applicant): The proposed research focuses on the development of novel therapeutic agents for the prevention and treatment of malaria caused by P. falciparum. A previous Phase ...
SBIRPhase II2012Department of Health and Human Services National Institutes of Health -
Preclinical Studies of Natural Product Derivatives as Antimalarial Agents
Amount: $998,181.00DESCRIPTION (provided by applicant): This project focuses on the development of a novel therapeutic agent for preventing and treating P. falciparum malaria. A two-year Phase I research has discovered ...
SBIRPhase II2011Department of Health and Human Services National Institutes of Health -
Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum
Amount: $600,000.00DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Pre-Clinical Evaluation of Antimalarial Natural Products from Carica papaya L.
Amount: $590,628.00DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...
SBIRPhase I2008Department of Health and Human Services National Institutes of Health -
Development of Natural Product as Antimalarial Agent
Amount: $299,880.00DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...
SBIRPhase I2007Department of Health and Human Services National Institutes of Health -
Pre-Clinical Development of Natural Product Analogues as Antimalarial Agents
Amount: $604,800.00DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...
SBIRPhase II2006Department of Health and Human Services National Institutes of Health -
Synthesis and Evaluation of Novel Antimalarial Agents
Amount: $100,000.00DESCRIPTION (provided by applicant): The long-term goal of this research is to develop drugs that are safe and effective against drug-resistant malaria. Malaria is one of the most common infectious di ...
SBIRPhase I2005Department of Health and Human Services National Institutes of Health
